Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

PURPOSE: The EML4-ALK fusion oncogene represents a novel molecular target in a small subset of non–small-cell lung cancers (NSCLC). To aid in identification and treatment of these patients, we examined the clinical characteristics and treatment outcomes of patients who had NSCLC with and without EML...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shaw, Alice T., Yeap, Beow Y., Mino-Kenudson, Mari, Digumarthy, Subba R., Costa, Daniel B., Heist, Rebecca S., Solomon, Benjamin, Stubbs, Hannah, Admane, Sonal, McDermott, Ultan, Settleman, Jeffrey, Kobayashi, Susumu, Mark, Eugene J., Rodig, Scott J., Chirieac, Lucian R., Kwak, Eunice L., Lynch, Thomas J., Iafrate, A. John
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2009
Materias:
Original Reports
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744268/
https://ncbi.nlm.nih.gov/pubmed/19667264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.6993
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares